Roberto Santiago was born on July 16th in the year 1958 in […]

Equities First Holdings is a leading company that offers alternative sources of […]

If you live near or in the Greater Austin, Texas Area then […]

Maximizing Dating Chances With Whitney Wolfe

For single people, it is very important to maximize the chances at dating. While not everyone has equal chances at the dating game, there are ways that people can play to their strengths. Everyone who is honest with themselves will understand that they may be attracted to different things. However, some of the turn offs are going to be a little less varied. For instance, people are not looking for someone who does not take care of himself. Therefore, it is important for people to take pride in themselves and develop good relationships with themselves so that they can have a better shot at dating.

Whitney Wolfe has advice for people that are willing to maximize their chances. One thing that is certain is that no one is going to get more than what they put out. One of the best things one can do in order to find a good match is to do more than just be oneself. People have to bring out their best self. This includes finding good clothes that they want to dress in. Once they find their own style, then they will have an easier time attracting the right mate. For one thing, if they dress well, but not in the style they want, then they may attract the wrong one.

Click here to learn more about Whitney Wolfe.

Whitney Wolfe is someone who knows how to bring out her own style so that she can be in the right relationships. She is also someone who knows how to grow. Whitney Wolfe’s growth has resulted in the dating app Bumble. Whitney Wolfe has looked at the dating app market and found ways that she can improve on them. Bumble puts the responsibility on the woman to message a match. The men can also enjoy some of the attention they want from women with Bumble.

Keep Reading: Austin’s Bumble Founder Transforms More Than Online Dating For Women

Posted in Dating Apps | Leave a comment

It is a medical journal that talks about the research on Oncology a branch of medicine that deals with the diagnosis, prevention, and treatment of cancer. It entails all molecules, pathways and cellular functions found in cancer cells and microbes.

The journal Oncotarget was founded in the year 2010 and is published by Impact Journals. Its editors in chief are Andrei V. Gudkov and Mikhail V. Blagosklonny all who are based at Roswell Park Cancer Institute, Buffalo, NY.

The oncotargets aim is to make available all the scientific research, results and to allow the sharing of discoveries’. It eliminates the borders between the specialists as the researchers are to contribute and help fight the disease.

The Oncotarget Journal published an article Vol 7. No 47 E-cigarettes and flavorings induce inflammatory…E-cigs to have a significant proportion of tobacco consumption which may cause an oral problem. Oxidative stress via carbonyl protein causes DNA damage inflammation.It creates a state of growth that brings chronic inflammation in gingival epithelium leading to the pathogenesis of an oral disease. E-cigs create more oxidative stress and inflammatory cytokine in human’s periodontal ligaments. Increased levels of prostaglandin E2 and cytoxygenase-2 are brought by advanced glycation end products are as a result of increased oxidative and inflammatory response and damage of DNA together with histone deacetylase 2 (HDAC2) in the gingival epithelium is due to E-cigs. Flavored E-cigs elicit the greater response. The response in periodontal cells may result in increased oxidative stress, pro-inflammatory, and pro-senescence. There is data to show the role of E-cig aerosol and its flavoring to cells and tissue of the mouth with oral health. Read more about the journal at

The journal publishes results of researches done by specialists and oncologist. Its achieves found on its website where they have all their images for a view. As of 2015, the onto target had a relatively high impact factor which is expected to grow.

Oncotarget is found in almost all social media sites and different languages. This is to allow easy access and ease of sharing information. Visit dovepress for more info.

Gastric cancer is also known as stomach cancer starts in the innermost layer of the stomach wall. The bacteria called H. pylori is the common source of the stomach cancer. Old age is also a risk factor. There is no clear way to cure stomach cancer though researchers are still trying to find its treatment. Taking antibiotics helps reduce gastric cancer.

Posted in Cancer Research | Leave a comment

NexBank Capital, Inc. is a financial Institute that serves their clients through three types of critical businesses such as; Commercial Banking, Mortgage Banking and Institutional Services– to provide high performance solutions that meet their customers’ complex and specialized needs.

NexBank also provides financial and banking services to the leading financial institutions, institutional clients, corporations and individuals’ nationwide. Initially, NexBank SSB was known as Heritage Bank and it changed its name to NexBank SSB in August, 2005. NexBank’s money market are rated to be 2X the national average.

The headquarters of NexBank is in Dallas, and it is ranked as the fourteenth largest bank in the state of Texas not forgetting it is also the 240th largest bank in the nation. The NexBank was established in 1934 and by September of 2016, it had grown rapidly to as much as eighty-nine employees at 4 locations. Currently, NexBank SSB functions as a subsidiary of NexBank Capital, Inc.

NexBank is well known for better industrial leadership and its commitment to their clients, NexBank always strives to provide exceptional value at every opportunity that arises. They provide their clients with classified solutions that are delivered by highly experienced professionals with track records of success that are proven and cannot be rivaled. NexBank serves the banking community with a charter that dates back to 1922.


Posted in FINANCIAL INSTITUTE | Leave a comment
A Serious Plumbing Problem Requires An Experienced Professional!

The Sunny Plumber Company, is headquartered in Tucson, Arizona and always ready to provide services to quickly solve your problem in most areas of Arizona, Nevada and California. They are the people who have the parachutes you need when something goes haywire in your plumbing system. And once you give Sunny Plumber a try, you’ll discover why customers choose Sunny Plumber as their brightest choice – get it? Look, folks, a handyman like your uncle Fred can usually fix the little plumbing stuff that happens more often than not. But when it comes to serious plumbing headaches, you need a professional like Sunny Plumber to come to the rescue

In the Southwest part of this country, there are many senior citizens who live or rent, and the last thing they need is to have a sewer or drain backup or a water heater that hasn’t seen a repair or replacement since Bush was president. Older people need to have a plumbing company they can trust as well as afford. Sunny Plumber is that company that suggests that there is no substitute for experience and has an ongoing motto: “if you’re not satisfied, Sunny Plumber is not satisfied.” So it all boils down to this. If you want a plumber who provides quick response, is professional, most often same day service, no hassle as well as no nonsense and really do know what they are doing plus be there when you need them, perhaps it’s time to switch plumbers and get on board the Sunny Plumber service train that shines.

Note: Sunny Plumber is licensed, bonded and insured and has a A+ and BBB certification. Yes, folks, this is the place where you’ll get all the plumbing services you’ll ever require. Got plumbing problems? Sunny Plumber has the parachute you need.


Posted in Plumbing | Leave a comment
Capitol Anesthesiology : The Leading Anesthesiology Association in Texas

Capitol Anesthesiology Association was established in 1973 and is the leading anesthesiology associations in the state. It has nearly 100 professionals that are highly qualified and have years of experience. These physicians also specialize in this particular field. Although Capitol Anesthesiology is based in Austin, TX, it practices in several treatment centers in the state of Texas and over fifteen emergency surgery centers. The CAA is also involved in the local community offering some of its services for seven different programs and institutions to those who may not have them otherwise.


Capital Anesthesiology Association offers common and specilized services such as:


  • General Anesthesia
  • Regional Anesthesia
  • Local/MAC (Monitored Anesthesia Care)
  • Pediatric Anesthesia
  • Obstetric Anestheisa
  • Cardio and Thoracic Anesthesia



While every hospital may need an anesthesiologist, it’s important to consider what special qualifications are needed. Most anesthesiologists know the procedure for general anesthesia that will be needed for a patient who is about to undergo an appendectomy. When it comes to certain patients with higher risks such as a child or a pregnant woman, the procedure can be quite different and requires a special skill and knowledge.


All physicians you will find in the Capitol Anesthesiology Associations team are board-certified by the American Board of Anesthesiology or are in the pursuit of board certification. This applies to all members of the Capitol Anesthesiology Association team including registered nurses or medical technicians.   Click here for more info.  To make it easier for both patients and treatment facilities, Capitol Anesthesiology Association accepts insurance from nearly 30 different companies.

Visit for related articles

Posted in Medical Services | Leave a comment
Why Mikhail Blagosklonny is a Reputable Oncologist

Mikhail Blagosklonny is a renowned scientist who has made a name for himself in oncology and anti-aging medicine. Some of his areas of interest in research include molecular biology and medical investigations including fresh anticancer strategies, anticancer therapeutics cell cycle and many others.

Education and Career Background

Blagosklonny is an alumnus of the First Pavlov State Medical University based in St. Petersburg where he attained an M.D in internal medicine as well as a Ph.D. in cardiology and experimental medicine. Following his academic accomplishment, he embarked on his first job at the New York Medical College in Valhalla, NY where he worked as an associate professor of medicine. This was before he joined Ordway Research Institute in the capacity of senior scientist. View more of his profile in LinkedIn.

Mikhail held the senior scientist position until he was appointed to serve as a professor of oncology at the Roswell Park Cancer Institute. His work in the institute ranges from teaching to undertaking cancer-related research. Since joining the institute, Mikhail has significantly helped in facilitating the creation of new anti-cancer strategies and methods.

Hypothesis on Aging and the Use of Rapamycin

Blagosklonny is widely known for the formulation of a hypothesis regarding the functions of TOR signaling in cancer and aging. In fact, he proposed the use of rapamycin, which is a prominent cancer drug used as a prospective treatment for life extension. As such, Mikhail Blagosklonny is considered as one of the avid proponents for rapamycin in the research for longevity.

Author and Editor

Apart from being a reputable scientist, Blagosklonny has written and published more than 270 papers, especially in peer-reviewed journals. Most of these papers have received more than 25000 citations, which have made him garner an h-index of 83.

Blagosklonny serves as an editor-in-chief of Cell Cycle, Aging and Oncotarget. Oncotarget is a popular medical journal published by Impact Journal that specializes in oncology. It is peer-reviewed, open access journal that is released each week. Additionally, Blagosklonny is the current associate editor of Cancer Biology & Therapy and editorial board member of the Cell Death & Differentiation. He has previously served on the editorial board of PLOS ONE, Cancer Research, Autophagy and International J Cancer.

Posted in Health Alerts | Leave a comment
An Overview Of Scientist Clay Siegall And His Firm Seattle Genetics

Clay Siegall’s Educational Background

Clay Siegall finished his undergraduate studies at the University of Maryland. His program of study there was a bachelors of science in zoology. After completing his undergraduate studies, Clay Siegall enrolled at George Washington University for post graduate studies. After several years of study there, he completed his PhD. degree in genetics at George Washington University in Washington D.C.

After completing his PhD. in genetics, Dr. Siegall joined the National Cancer Institute, which is a part of the National Institutes of Health. He was welcomed as a staff fellow and biotechnology fellow at the National Cancer Institute. His work involved trying to find cures for cancer and the study of the cause and progression of the disease. Mr. Siegall worked for the National Institute of Health for a total of three years, lasting from February of 1998 until February 1991.

Clay Siegall’s next job was with the Bristol-Myers Squibb Pharmaceutical Research Institute. He began working as a senior research investigator for Bristol-Myers. Dr. Siegall held that post from February of 1991 until January of 1995. He eventually received a promotion at the Bristol-Myers Squibb Pharmaceutical Research Institute and was appointed as a principal scientist, beginning in January of 1995. Clay Siegal would stay at Bristol-Myers for two more years, before he left the firm in December of 1997.

After leaving Bristol-Myers Squibb, Dr. Siegall co-founded his own cancer research and drug development company that was named Seattle Genetics. It was so named, because it was based out of the Seattle metro area. Today Seattle Genetics has its headquarters in Bothell, Washington. It is a suburban community that is just outside of the city of Seattle.

Seattle Genetics, which is led by, president and chief executive officer, Clay Siegall is a pioneer in new cancer therapies. One of these new therapies designed by Seattle Genetics is antibody-drug-conjugates. This new therapy uses the targeting ability of anti-bodies and the power of chemotherapy to better target cancerous cells. At the same time, the targeting of only cancerous cells lessens the likelihood that normal healthy cells will be destroyed during the cancer treatment.

Posted in Chemotherapy | Leave a comment